🔗 Visit the ClinicalTrials.gov page for NCT01649921
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis. | Crit Care | 2014 | 1.48 |
| 2 | The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer? | Virulence | 2013 | 1.15 |
| 3 | Emerging therapeutic targets of sepsis-associated acute kidney injury. | Semin Nephrol | 2015 | 0.81 |
| 4 | Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression. | Pharmacol Res | 2016 | 0.79 |